查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1466199

心房顫動手術市場：按產品、適應症和最終用戶 - 2024-2030 年全球預測

Atrial Fibrillation Surgery Market by Product (Cardiac Cryoablation Catheters, Cardiac Mapping System), Indication (Atrial Fibrillation (AFib), Atrial Flutter, Supraventricular Tachycardia (SVT)), End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

心房顫動手術市場規模預估2023年為26.7億美元，2024年達29億美元，預估2030年將達48.8億美元，複合年成長率為9.00%。

心房顫動手術是治療心房顫動 (AFib) 的醫療程序。心房顫動通常是一種不規則且快速的心率，可導致血流不良、中風和其他心血管併發症。心房顫動手術的主要類型包括心導管電氣燒灼術、手術消融和左心耳封堵術（LAAC）。多年來，糖尿病和高血壓等慢性疾病的盛行率顯著增加，這些慢性疾病是心房顫動發生的主要危險因素，導致對有效心房顫動治療方案的需求急劇增加。心導管電氣燒灼術等微創技術的創新顯著改善了患者的治療效果，同時縮短了恢復時間。然而，與心房顫動手術產品相關的產品召回、手術報銷的限制以及執行手術的外科醫生的有限性也對市場產生了影響。市場參與者正在開發價格實惠的設備和技術，以改善不同社會經濟背景的患者獲得救生治療的機會。人工智慧、機器人和生物電子醫學等領域的持續研究有望開發出創新的心房顫動手術解決方案，進一步改善患者的治療效果並最大限度地減少併發症。

主要市場統計
基準年[2023] 26.7億美元
預測年份 [2024] 29億美元
預測年份 [2030] 48.8億美元
複合年成長率（%） 9.00%

使用產品導管進行微創手術的需求正在增加。

心導管電氣燒灼術產品是微創手術，用於透過隔離肺靜脈並在心臟組織中產生損傷來破壞異常電訊號來治療心房顫動 (AF)。這些產品為不適合進行心臟直視手術或希望更快恢復時間的患者提供了一種侵入性較小的選擇。外科消融產品包括多種技術，例如迷宮（剪切和粘貼）、射頻 (RF) 消融和冷凍消融，在心臟直視手術期間或採用包括胸腔鏡手術在內的微創方法進行。這些產品可解決更複雜的心律不整問題，而僅使用基於導管的技術無法有效治療這些心律不整。儘管基於導管的手術是首選，因為它們具有微創性並且可以快速恢復，但手術選擇可以為僅通過基於導管的手術無法充分解決的複雜心律不整提供更全面的治療。

迷宮手術作為適應性心房顫動的首選治療方法的出現

心律不整是由心臟異常電活動引起的心律不整。心房顫動是最常見的心律不整，影響著全世界數百萬人。迷宮手術、肺靜脈隔離（PVI）和左心耳阻塞術（LAAC）是治療心房顫動的常見外科手術。心房撲動是一種較不常見的心律不整，其特徵是源自心房的快速、規則的電訊號。如果心導管電氣燒灼術是首選治療方法，但由於患者因素導致消融不成功或不適合，則可能需要進行心房顫動手術。室上性心搏過速是發生在心室上方的快速心率。心導管電氣燒灼術是SVT的主要治療方法，當有多個致心律不整病灶或消融失敗時可考慮心房顫動手術。

最終用戶：加快在循環系統醫學和多中心環境中進行心房顫動手術的速度

在心房顫動手術中，循環系統和多學科實踐對於心房顫動手術介入都有不同的要求和偏好。循環系統科診所優先考慮專門為心房顫動治療設計的設備，而多學科診所則需要跨學科和患者群體的多功能性。循環系統專門診斷和治療包括心房顫動在內的心臟疾病，需要先進的設備和技術，以及新型沖洗式射頻消融導管。心導管電氣燒灼術等微創方法因其成功率高、減少患者不適且恢復時間更快而受到循環系統的青睞。多專業實踐透過將各種醫學專業集中在一個屋簷下，提供了一種全面的患者照護方法。在這些環境中，心電圖機、超音波心動圖系統和心臟監測設備等診斷設備和工具用於準確診斷和治療心房顫動。

區域洞察

在成熟的醫療基礎設施和執行外科手術的有利報銷政策的推動下，北美市場格局正在不斷發展。該地區擁有多種獲得美國食品藥物管理局（FDA）和加拿大衛生署核准的創新藥物和醫療設備，改善了開發環境。在亞太地區，隨著越來越多的心血管疾病患者接受手術，心房顫動手術在印度、日本和中國等國家迅速增加。亞洲醫療旅遊業的顯著成長正在加速該地區進行的手術數量，並擴大了對先進手術工具和設備的需求。亞洲的心房顫動手術產量正在成長，特別是在中國和日本。這是因為領先的醫療設備製造商專注於開發具有成本效益的解決方案，以滿足對負擔得起的醫療服務不斷成長的需求。歐洲是心房顫動的另一個重要市場，許多歐洲公司專注於開發用於心房顫動手術的創新心臟設備。各大公司正大力投資研發活動，旨在改善手術技術，以有效治療心房顫動患者。

FPNV定位矩陣

FPNV定位矩陣對於評估心房顫動手術市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對心房顫動手術市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告在以下方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4. 競爭評估和情報：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.房顫手術市場規模及預測如何？

2.在心房顫動手術市場的預測期內，有哪些產品、細分市場、應用和領域需要考慮投資？

3.心房顫動手術市場的技術趨勢和法規結構是什麼？

4.心房顫動手術市場主要廠商的市場佔有率是多少？

5.進入心房顫動手術市場的合適型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 老年人心房顫動盛行率上升
      • 心律不整治療中優先考慮心導管電氣燒灼術
      • 增加 AF 項目以提高公眾意識
    • 抑制因素
      • 與設備相關的監管問題
    • 機會
      • 對微創手術、較小的心臟切口和更短的術後恢復時間的需求日益成長。
      • 心房顫動心導管電氣燒灼術技術進展
    • 任務
      • 缺乏熟練的專業人員和公眾缺乏手術意識
  • 市場區隔分析
    • 產品：隨著基於導管的手術的使用越來越多，對微創手術的需求也在增加。
    • 適應症：迷路手術作為心房顫動的首選治療方法的出現
    • 最終用戶：加速心臟病學和多專科中心進行的心房顫動手術
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章心房顫動手術市場：依產品

  • 心臟冷凍消融導管
  • 心臟定位系統

第7章 心房顫動手術市場（按適應症）

  • 心房顫動 (AFib)
  • 心房撲動
  • 心室上性心搏過速 (SVT)

第8章心房顫動手術市場：依最終用戶分類

  • 心臟病學
  • 多專業

第9章北美和南美心房顫動手術市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區心房顫動手術市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲的心房顫動手術市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • GE 醫療保健推出用於治療心房顫動的 CardioVisio。它是一種以患者為中心的數位化臨床決策支援工具，可實現精準護理。
    • Biosense Webster 獲得 FDA核准多種心房顫動消融產品，這些產品可用於無需透視的工作流程
    • Medtronic)用於房性心律不整治療的 Aphera 標測和消融系統獲得 CE 標誌核准
  • 戰略分析和建議

第13章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-436901065DB6

[182 Pages Report] The Atrial Fibrillation Surgery Market size was estimated at USD 2.67 billion in 2023 and expected to reach USD 2.90 billion in 2024, at a CAGR 9.00% to reach USD 4.88 billion by 2030.

Atrial fibrillation surgery is a medical procedure to treat atrial fibrillation (AFib), an irregular and often rapid heart rate that can lead to poor blood flow, stroke, and other cardiovascular complications. Major types of atrial fibrillation surgeries include catheter ablation, surgical ablation, and left atrial appendage closure (LAAC). Over the years, there has been a significant prevalence of chronic diseases such as diabetes and hypertension, which are key risk factors for developing AFib; as a result, demand for effective AFib treatment options has surged. Innovations in minimally invasive techniques, such as catheter ablation, have significantly improved patient outcomes while reducing recovery time. However, product recalls associated with AFib surgical products, limited reimbursements for surgeries, and limited availability of surgeons to conduct the procedure also impact the market. Market players are creating affordable devices or techniques that enable greater accessibility to life-saving treatments for patients across different socioeconomic backgrounds. Continued research in areas such as artificial intelligence, robotics, and bioelectronic medicine is expected to lead to the development of innovative AFib surgery solutions that further improve patient outcomes and minimize complications.

KEY MARKET STATISTICS
Base Year [2023] USD 2.67 billion
Estimated Year [2024] USD 2.90 billion
Forecast Year [2030] USD 4.88 billion
CAGR (%) 9.00%

Product: Minimally invasive procedures are on demand with the rising utilization of catheter-based procedures

Catheter ablation products are minimally invasive procedures used to treat atrial fibrillation (AF) by isolating the pulmonary veins and creating lesions in the heart tissue to disrupt the abnormal electrical signals. These products offer a less invasive option for patients who are not suitable candidates for open-heart surgery or those who prefer a shorter recovery time. Surgical ablation products encompass various techniques such as maze procedure (cut-and-sew technique), radiofrequency (RF) ablation, and cryoablation performed during open-heart surgery or using minimally invasive approaches, including thoracoscopic surgery. These products address more complex cardiac arrhythmias that cannot be effectively treated alone with catheter-based techniques. While catheter-based procedures are favored due to their minimally invasive nature and quicker recovery times, surgical options offer a more comprehensive treatment for complex arrhythmias that cannot be adequately addressed using catheter techniques alone.

Indication: Emergence of maze procedure as a preferred treatment for atrial fibrillation

Arrhythmias are irregular heart rhythms induced by abnormal electrical activity in the heart. Atrial fibrillation is the most common type of arrhythmia affecting millions of people worldwide. The maze procedure, pulmonary vein isolation (PVI), and left atrial appendage closure (LAAC) are common surgical options for AFib treatment. Atrial flutter is a less common arrhythmia characterized by rapid and regular electrical signals originating from the atria. Catheter ablation is the preferred treatment option; however, atrial fibrillation surgery may be necessary in cases where ablation is unsuccessful or not suitable due to patient factors. Supraventricular tachycardia refers to rapid heart rhythms originating above the ventricles. Catheter ablation is the primary treatment for SVT, and atrial fibrillation surgery may be considered in cases with multiple arrhythmogenic foci or when ablation fails.

End-User: Accelerating cases of atrial fibrillation surgeries conducted in cardiology and multi-specialty centers

In the atrial fibrillation surgery landscape, cardiology and multi-specialty practices have distinct requirements and preferences regarding surgical interventions for atrial fibrillation. Cardiology-focused practices prioritize specialized devices explicitly designed for atrial fibrillation treatment, while multi-specialty settings seek versatility across disciplines and patient populations. Cardiologists specialized in diagnosing and treating heart diseases, including atrial fibrillation, necessitating advanced devices and procedures and new irrigated radiofrequency ablation catheters. Minimally invasive methods such as catheter ablation are the preferred choice for cardiologists due to their high success rates, reduced patient discomfort, and shorter recovery times. Multi-specialty practices provide an integrated approach to patient care by encompassing various medical disciplines under one roof. In these settings, diagnostic equipment and tools comprise ECG machines, echocardiography systems, and cardiac monitoring devices for accurate diagnosis and management of atrial fibrillation.

Regional Insights

North America's atrial fibrillation surgery market observes an advancing landscape driven by the well-established healthcare infrastructure and favorable reimbursement policies to conduct surgical procedures. There have been several innovative medication products and devices approved by the U.S. Food & Drug Administration (FDA) and Health Canada in the region, portraying an improved development scenario. In Asia-Pacific, countries such as India, Japan, and China have seen a rapid increase in AFib surgeries due to a large patient pool suffering from cardiovascular diseases uptaking surgical procedures. Substantial growth in medical tourism in Asia has accelerated the number of surgeries conducted in the region, expanding the need for advanced surgical tools and devices. The production aspect of AF surgery is growing in Asia, especially in China and Japan, due to the presence of major medical device manufacturers focusing on developing cost-effective solutions to cater to the ever-growing demand for affordable healthcare services. Europe is another significant market for AFib, with many European-based companies focusing on developing innovative cardiac devices used during AF surgeries. Key players have made substantial investments in research and development activities aimed at advancing surgical technologies for treating atrial fibrillation patients effectively.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Atrial Fibrillation Surgery Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Atrial Fibrillation Surgery Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Atrial Fibrillation Surgery Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acesion Pharma ApS, Acutus Medical, Inc, Affera, Inc., AFreeze GmbH, Atrian Medical Ltd., AtriCure, Inc., AuriGen Medical, BIOTRONIK SE & CO. KG, Boston Scientific Corporation, Cardiofocus, Inc., CathRx Ltd, Cook Group Incorporated, F. Hoffmann-La Roche AG, GE HealthCare Technologies Inc., Healium Medical, Japan Lifeline Co., Johnson & Johnson Services, Inc., Kardium Inc., Koninklijke Philips N.V., Medtronic PLC, OMEICOS Therapeutics GmbH, Osypka AG, SentiAR, Inc, Siemens Healthcare GmbH, Stryker Corporation, Terumo Corporation, Thryv Therapeutics Inc., Toray Medical Co., Ltd., Vanguard AG, and Volta Medical.

Market Segmentation & Coverage

This research report categorizes the Atrial Fibrillation Surgery Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Cardiac Cryoablation Catheters
    • Cardiac Mapping System
  • Indication
    • Atrial Fibrillation (AFib)
    • Atrial Flutter
    • Supraventricular Tachycardia (SVT)
  • End-User
    • Cardiology
    • Multi Specialities
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Atrial Fibrillation Surgery Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Atrial Fibrillation Surgery Market?

3. What are the technology trends and regulatory frameworks in the Atrial Fibrillation Surgery Market?

4. What is the market share of the leading vendors in the Atrial Fibrillation Surgery Market?

5. Which modes and strategic moves are suitable for entering the Atrial Fibrillation Surgery Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in prevalence of atrial fibrillation in geriatric population
      • 5.1.1.2. Development in preference of catheter ablation for cardiac arrhythmia treatment
      • 5.1.1.3. Growing number of AF programs to enhance public awareness
    • 5.1.2. Restraints
      • 5.1.2.1. Regulatory issues associated with the devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing need for minimally invasive procedures, smaller cardiac incisions, and faster post-surgical recovery times
      • 5.1.3.2. Technological advances for catheter ablation of atrial fibrillation
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of skilled professionals and awareness among the people about the surgery
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Minimally invasive procedures are on demand with the rising utilization of catheter-based procedures
    • 5.2.2. Indication: Emergence of maze procedure as a preferred treatment for atrial fibrillation
    • 5.2.3. End-User: Accelerating cases of atrial fibrillation surgeries conducted in cardiology and multi-specialty centers
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Atrial Fibrillation Surgery Market, by Product

  • 6.1. Introduction
  • 6.2. Cardiac Cryoablation Catheters
  • 6.3. Cardiac Mapping System

7. Atrial Fibrillation Surgery Market, by Indication

  • 7.1. Introduction
  • 7.2. Atrial Fibrillation (AFib)
  • 7.3. Atrial Flutter
  • 7.4. Supraventricular Tachycardia (SVT)

8. Atrial Fibrillation Surgery Market, by End-User

  • 8.1. Introduction
  • 8.2. Cardiology
  • 8.3. Multi Specialities

9. Americas Atrial Fibrillation Surgery Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Atrial Fibrillation Surgery Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Atrial Fibrillation Surgery Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. GE HealthCare Launches CardioVisio for Atrial Fibrillation, a Digital, Patient-Centric Clinical Decision Support Tool to Enable Precision Care
    • 12.3.2. Biosense Webster Receives FDA Approval for Multiple Atrial Fibrillation Ablation Products to be Used in a Workflow Without Fluoroscopy
    • 12.3.3. Medtronic Receives CE Mark Approval For Affera Mapping And Ablation System To Treat Atrial Arrhythmias
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. ATRIAL FIBRILLATION SURGERY MARKET RESEARCH PROCESS
  • FIGURE 2. ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ATRIAL FIBRILLATION SURGERY MARKET DYNAMICS
  • FIGURE 7. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ATRIAL FIBRILLATION SURGERY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. ATRIAL FIBRILLATION SURGERY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ATRIAL FIBRILLATION SURGERY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY CARDIAC CRYOABLATION CATHETERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY CARDIAC CRYOABLATION CATHETERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY CARDIAC MAPPING SYSTEM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY CARDIAC MAPPING SYSTEM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ATRIAL FIBRILLATION (AFIB), BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ATRIAL FIBRILLATION (AFIB), BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ATRIAL FLUTTER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ATRIAL FLUTTER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SUPRAVENTRICULAR TACHYCARDIA (SVT), BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SUPRAVENTRICULAR TACHYCARDIA (SVT), BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY CARDIOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY MULTI SPECIALITIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY MULTI SPECIALITIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 28. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 29. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 30. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 31. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 32. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 33. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 34. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 35. ARGENTINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 36. ARGENTINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 37. ARGENTINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 38. ARGENTINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 39. ARGENTINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 40. ARGENTINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 41. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 42. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 43. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 44. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 45. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 46. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 47. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 48. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 49. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 50. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 51. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 52. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 53. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 54. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 55. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 56. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 57. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 58. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 59. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 60. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 61. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 62. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 63. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 64. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 65. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 66. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 76. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 78. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 80. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 81. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 82. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 83. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 84. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 85. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 86. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 87. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 88. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 89. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 90. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 91. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 92. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 93. INDONESIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 94. INDONESIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 95. INDONESIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 96. INDONESIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 97. INDONESIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 98. INDONESIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 99. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 100. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 101. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 102. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 103. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 104. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 105. MALAYSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 106. MALAYSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 107. MALAYSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 108. MALAYSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 109. MALAYSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 110. MALAYSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 112. PHILIPPINES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 114. PHILIPPINES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 116. PHILIPPINES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 117. SINGAPORE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 118. SINGAPORE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 119. SINGAPORE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 120. SINGAPORE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 121. SINGAPORE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 122. SINGAPORE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 124. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 126. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 128. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 129. TAIWAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 130. TAIWAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 131. TAIWAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 132. TAIWAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 133. TAIWAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 134. TAIWAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 135. THAILAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 136. THAILAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 137. THAILAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 138. THAILAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 139. THAILAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 140. THAILAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 141. VIETNAM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 142. VIETNAM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 143. VIETNAM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 144. VIETNAM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 145. VIETNAM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 146. VIETNAM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 155. DENMARK ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 156. DENMARK ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 157. DENMARK ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 158. DENMARK ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 159. DENMARK ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 160. DENMARK ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 161. EGYPT ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 162. EGYPT ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 163. EGYPT ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 164. EGYPT ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 165. EGYPT ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 166. EGYPT ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 167. FINLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 168. FINLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 169. FINLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 170. FINLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 171. FINLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 172. FINLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 173. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 174. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 175. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 176. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 177. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 178. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 179. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 180. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 181. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 182. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 183. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 184. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 185. ISRAEL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 186. ISRAEL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 187. ISRAEL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 188. ISRAEL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 189. ISRAEL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 190. ISRAEL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 191. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 192. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 193. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 194. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 195. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 196. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 198. NETHERLANDS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 200. NETHERLANDS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 202. NETHERLANDS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 203. NIGERIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 204. NIGERIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 205. NIGERIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 206. NIGERIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 207. NIGERIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 208. NIGERIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 209. NORWAY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 210. NORWAY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 211. NORWAY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 212. NORWAY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 213. NORWAY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 214. NORWAY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 215. POLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 216. POLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 217. POLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 218. POLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 219. POLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 220. POLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 221. QATAR ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 222. QATAR ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 223. QATAR ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 224. QATAR ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 225. QATAR ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 226. QATAR ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 227. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 228. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 229. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 230. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 231. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 232. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 234. SAUDI ARABIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 236. SAUDI ARABIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 238. SAUDI ARABIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 240. SOUTH AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 242. SOUTH AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 244. SOUTH AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 245. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 246. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 247. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 248. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 249. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 250. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 251. SWEDEN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 252. SWEDEN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 253. SWEDEN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 254. SWEDEN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 255. SWEDEN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 256. SWEDEN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 258. SWITZERLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 260. SWITZERLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 262. SWITZERLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 263. TURKEY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 264. TURKEY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 265. TURKEY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 266. TURKEY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 267. TURKEY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 268. TURKEY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 276. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 278. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 281. ATRIAL FIBRILLATION SURGERY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 282. ATRIAL FIBRILLATION SURGERY MARKET, FPNV POSITIONING MATRIX, 2023